SOX2 drives progression and therapy resistance in advanced prostate cancer
Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage…
New ‘dual-mode’ tracer agent enhances precision in prostate cancer procedures
A preclinical evaluation of a new ‘dual-mode’ tracer agent shows promise in not only helping surgeons image and…
Should Chest CT be Routine for Prostate Cancer Patients on Androgen Deprivation Therapy?
For patients receiving androgen deprivation therapy (ADT) for prostate cancer (PCa), emerging research affirms that assessing myocardial extracellular…